rs28934578
|
|
T |
0.820 |
CausalMutation |
CLINVAR |
Heterogeneity of Li-Fraumeni syndrome links to unequal gain-of-function effects of p53 mutations.
|
24573247 |
2014 |
rs121912651
|
|
A |
0.820 |
CausalMutation |
CLINVAR |
A young woman with bilateral breast cancer: identifying a genetic cause and implications for management.
|
23667202 |
2013 |
rs121912651
|
|
A |
0.820 |
CausalMutation |
CLINVAR |
Clinical response to a lapatinib-based therapy for a Li-Fraumeni syndrome patient with a novel HER2V659E mutation.
|
23950206 |
2013 |
rs121912666
|
|
C |
0.820 |
CausalMutation |
CLINVAR |
Small molecule induced reactivation of mutant p53 in cancer cells.
|
23630318 |
2013 |
rs28934578
|
|
T |
0.820 |
CausalMutation |
CLINVAR |
p53 mutations in cancer.
|
23263379 |
2013 |
rs28934578
|
|
T |
0.820 |
CausalMutation |
CLINVAR |
A common p53 mutation (R175H) activates c-Met receptor tyrosine kinase to enhance tumor cell invasion.
|
23792586 |
2013 |
rs121912651
|
|
C |
0.820 |
GeneticVariation |
CLINVAR |
FOXM1 is a molecular determinant of the mitogenic and invasive phenotype of anaplastic thyroid carcinoma.
|
22919068 |
2012 |
rs121912651
|
|
A |
0.820 |
CausalMutation |
CLINVAR |
Mutant p53: one name, many proteins.
|
22713868 |
2012 |
rs121912666
|
|
C |
0.820 |
CausalMutation |
CLINVAR |
Rapid profiling of disease alleles using a tunable reporter of protein misfolding.
|
22923379 |
2012 |
rs121912666
|
|
C |
0.820 |
CausalMutation |
CLINVAR |
Early onset HER2-positive breast cancer is associated with germline TP53 mutations.
|
21761402 |
2012 |
rs28934576
|
|
T |
0.820 |
CausalMutation |
CLINVAR |
Mutant p53R273H attenuates the expression of phase 2 detoxifying enzymes and promotes the survival of cells with high levels of reactive oxygen species.
|
22899716 |
2012 |
rs28934578
|
|
T |
0.820 |
CausalMutation |
CLINVAR |
Early onset HER2-positive breast cancer is associated with germline TP53 mutations.
|
21761402 |
2012 |
rs121912651
|
|
C |
0.820 |
GeneticVariation |
CLINVAR |
Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: a prospective observational study.
|
21601526 |
2011 |
rs121912651
|
|
C |
0.820 |
GeneticVariation |
CLINVAR |
Dominant-negative features of mutant TP53 in germline carriers have limited impact on cancer outcomes.
|
21343334 |
2011 |
rs121912666
|
|
G |
0.820 |
CausalMutation |
CLINVAR |
Dominant-negative features of mutant TP53 in germline carriers have limited impact on cancer outcomes.
|
21343334 |
2011 |
rs121912666
|
|
C |
0.820 |
CausalMutation |
CLINVAR |
Identification of genetic susceptibility to childhood cancer through analysis of genes in parallel.
|
21356188 |
2011 |
rs121912666
|
|
C |
0.820 |
CausalMutation |
CLINVAR |
Dominant-negative features of mutant TP53 in germline carriers have limited impact on cancer outcomes.
|
21343334 |
2011 |
rs28934576
|
|
T |
0.820 |
CausalMutation |
CLINVAR |
Patient 1 with LFS and TP53(R273H) developed a rhabdomyosarcoma twice at the ages of 18 months and 21 years.
|
21484931 |
2011 |
rs28934576
|
|
T |
0.820 |
CausalMutation |
CLINVAR |
Gastric cancer in individuals with Li-Fraumeni syndrome.
|
21552135 |
2011 |
rs28934576
|
|
T |
0.820 |
CausalMutation |
CLINVAR |
Sebaceous gland carcinoma of the eyelid masquerading as a cutaneous horn in Li--Fraumeni syndrome.
|
20693561 |
2011 |
rs28934578
|
|
T |
0.820 |
CausalMutation |
CLINVAR |
Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing.
|
22006311 |
2011 |
rs28934578
|
|
T |
0.820 |
CausalMutation |
CLINVAR |
Mutant p53(R175H) upregulates Twist1 expression and promotes epithelial-mesenchymal transition in immortalized prostate cells.
|
20689556 |
2011 |
rs121912651
|
|
A |
0.820 |
CausalMutation |
CLINVAR |
TP53 germline mutation testing in 180 families suspected of Li-Fraumeni syndrome: mutation detection rate and relative frequency of cancers in different familial phenotypes.
|
20522432 |
2010 |
rs121912666
|
|
G |
0.820 |
CausalMutation |
CLINVAR |
Long-term outcomes of breast cancer in women aged 30 years or younger, based on family history, pathology and BRCA1/BRCA2/TP53 status.
|
20234365 |
2010 |
rs121912666
|
|
C |
0.820 |
CausalMutation |
CLINVAR |
Altered-function p53 missense mutations identified in breast cancers can have subtle effects on transactivation.
|
20407015 |
2010 |